A group of proteins that might confer susceptibility to emphysema has been identified. One of them is transforming growth factor-β, and the discovery highlights the many ways of activating this protein in health and disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Progress in the mechanism and targeted drug therapy for COPD
Signal Transduction and Targeted Therapy Open Access 27 October 2020
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Barnes, P. J. Annu. Rev. Med. 54, 113–129 (2003).
Morris, D. G. et al. Nature 422, 169–173 (2003).
Hautamaki, R. D. et al. Science 277, 2002–2004 (1997).
Joos, L. et al. Hum. Mol. Genet. 11, 569–576 (2002).
Munger, J. S. et al. Cell 96, 319–328 (1999).
Annes, J. P., Munger, J. S. & Rifkin, D. B. J. Cell Sci. 116, 217–224 (2003).
Feinberg, M. W. et al. J. Biol. Chem. 275, 25766–25773 (2000).
Wakefield, L. M. & Roberts, A. B. Curr. Opin. Genet. Dev. 12, 22–29 (2002).
Werner, F. et al. J. Biol. Chem. 275, 36653–36658 (2000).
Sterner-Kock, A. et al. Genes Dev. 16, 2264–2273 (2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roberts, A. Smoke signals for lung disease. Nature 422, 130–131 (2003). https://doi.org/10.1038/422130a
Issue Date:
DOI: https://doi.org/10.1038/422130a
This article is cited by
-
Progress in the mechanism and targeted drug therapy for COPD
Signal Transduction and Targeted Therapy (2020)